StockNews.com Upgrades Lexicon Pharmaceuticals (NASDAQ:LXRX) to Sell

StockNews.com upgraded shares of Lexicon Pharmaceuticals (NASDAQ:LXRX – Free Report) to a sell rating in a report released on Tuesday morning. A number of other research analysts have also recently commented on LXRX. Leerink Partnrs reissued an outperform rating on shares of Lexicon Pharmaceuticals in a report on Tuesday, April 30th. SVB Leerink began coverage […]

Leave a Reply

Your email address will not be published.

Previous post Q4 2024 Earnings Estimate for Mr. Cooper Group Inc. (NASDAQ:COOP) Issued By Wedbush
Next post CarMax (NYSE:KMX) Stock Rating Upgraded by StockNews.com